News in brief
Pandemic learnings and pest control developments: News from Imperial
Here’s a batch of fresh news and announcements from across Imperial.
Stories tagged with 'Public health'
Gene therapy
UK approves world-first gene-editing treatment for blood disorders
The UK has become the first country in the world to approve a gene therapy as a potential cure for two inherited blood disorders.
Neonatal numbers
Number of extremely premature babies receiving neonatal care triples
The number of babies born at 22 weeks given respiratory life support in England and Wales increased three-fold after NHS guidelines changed in 2019.
Collaborative exploration
Mohn Mingle networking and research meetings kick off with a bang
The Mohn Centre is pleased to announce the success of its new monthly networking and research meeting series - the Mohn Mingle.
Children for research
Mohn Centre secures collaborative funding for North West London
The Mohn Centre, with colleagues in North West London, has secured funding to investigate barriers of children participating in research.
IMAGINING INNOVATION
Imperial partners in UK’s first total-body PET platform for drug discovery
Imperial researchers are partners in a UK initiative to improve clinical imaging for research and the development of new treatments.
News in Brief
Climate awards and dangerous jobs: News from Imperial
Here's a batch of fresh news and announcements from across Imperial.
Community film screening
Mohn Centre Community Film Premieres in White City
Lights, camera, impact: The views of North West London’s children and young people are championed in short films by the community and the Mohn Centre.
Alzheimer’s awareness
Imperial’s Alzheimer’s research impact
To mark World Alzheimer’s Day, we explore how Imperial College London is advancing our knowledge of Alzheimer’s disease and other dementias.
COVID antibody test
COVID-19 antibody tests provide insights into risk of hospitalisation and death
Simple at-home antibody tests can help understand who may be at risk of poor health outcomes and inform timing and roll-out of COVID vaccine boosters.
